Sponsored by:

Molecular Imaging: Page 440

FDG-PET/CT aids in radiation therapy planning
By Wayne Forrest
For head and neck carcinoma, using FDG-PET/CT leads to more accurate staging, appropriate changes in radiation therapy planning, and potentially superior patient outcomes, according to a new study by researchers from Wisconsin.
March 4, 2008
Biotage, McMaster extend molecular imaging deal
By AuntMinnie.com staff writers
Swedish life sciences firm Biotage and McMaster University of Hamilton, Ontario, have inked a two-year extension to their molecular imaging development pact.
March 3, 2008
AMIC to begin isotope production
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) has installed a compact linear accelerator to provide isotope production capabilities in North America.
March 3, 2008
NuView inks deal with USC
By AuntMinnie.com staff writers
Radiopharmaceutical developer NuView Radiopharmaceuticals has signed an exclusive license agreement with the University of Southern California (USC) in Los Angeles.
March 2, 2008
IsoRay chief executive steps down
By AuntMinnie.com staff writers
The chief executive of medical isotope developer IsoRay of Richland, WA, has left the company.
February 26, 2008
Covidien gets tentative nod for generic sestamibi
By AuntMinnie.com staff writers
Covidien has received tentative approval from the U.S. Food and Drug Administration (FDA) for a generic version of the Cardiolite technetium sestamibi radiopharmaceutical for myocardial perfusion studies.
February 26, 2008
Firms combine to launch cardiac gamma camera
By AuntMinnie.com staff writers
Clinical information systems developer Aventyn of Carlsbad, CA, has partnered with Swedish medical device developer Adolesco to sell Cardiotom, a mobile tomographic gamma camera.
February 26, 2008
Nuclear medicine market nears $300 million
By AuntMinnie.com staff writers
The North American nuclear medicine market earned revenues of $298.4 million in 2007, according to a new market research report by Frost & Sullivan of San Antonio.
February 25, 2008
Isotope shows promise in brain cancer treatment
By Wayne Forrest
Researchers from the Duke University Medical Center in Durham, NC, are heralding early success with the isotope astatine-211 (At-211) in destroying residual cancer cells in the brain, while sparing healthy cells, and extending the lives of cancer patients. The therapy shows promising results for treating recurrent brain tumors and other cancers.
February 21, 2008
2008 02 21 16 12 03 706
Siemens wins mobile PET/CT contract
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, has installed the first of four Biograph 6 TruePoint PET/CT systems into mobile vehicles operated by InHealth Molecular Imaging Solutions.
February 20, 2008
Part I: Stroke imaging hones in on preventable infarction
By Eric Barnes
Our two-part series on acute stroke imaging presents current controversies in the field and the views of leading stroke researchers in neurology and radiology. Part I looks at image-guided treatment of at-risk brain tissue, patient selection, and study design.
February 20, 2008
2008 02 21 15 43 01 706
Bayer inks molecular imaging deal
By AuntMinnie.com staff writers
Bayer Schering Pharma has signed a license agreement with South Korean molecular imaging manufacturer FutureChem.
February 19, 2008
Previous Page
Page 440 of 612
Next Page